SB 5713
In CommitteeSenate
Chemical abortion
Concerning chemical abortion.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill establishes new legal and reporting requirements around chemical abortions in Washington State, including mandatory patient disclosures about legal liability for complications, civil penalties for providers who fail to comply, and new reporting obligations for complications. It also creates a private right of civil action for patients and family members and protects patient anonymity in legal proceedings.
- Requires health care providers to give patients specific written information about legal liability for complications before performing a chemical abortion, and obtain written patient certification that the information was provided.
- Creates civil liability for providers who perform or prescribe chemical abortions outside legal exceptions (e.g., medical emergency), allowing patients, spouses, maternal grandparents (if patient was minor or deceased), and next of kin (if patient died from complications) to sue for damages—including triple the cost of the abortion and compensation for physical/psychological injuries.
- Imposes civil penalties of up to $5,000 per day for violations of the informed consent requirement, and up to $10,000 per violation for failure to conduct reasonable informed consent; penalties fund pregnancy resource centers that do not perform or refer for abortions.
- Mandates reporting of chemical abortions and complications to the Department of Health within three business days, including details like drug used, source (e.g., mail-order), complications, and treatment; penalties of $500 per violation for noncompliance.
- Requires courts to preserve patient anonymity in legal proceedings unless the patient consents to disclosure, including sealing records and allowing pseudonyms for parties other than public officials or defendants.
- Prohibits criminal or civil penalties against patients who receive or seek chemical abortions, and clarifies that no penalties apply if a patient discloses their chemical abortion to emergency medical providers.
Who is affected
- Abortion pill providers and other health care providers (e.g., physicians, physician assistants, advanced practice registered nurses) — Must provide specific written information about legal liability and complications before performing a chemical abortion, and obtain written certification from the patient confirming this; failure to comply can result in civil penalties up to $5,000 per day and additional fines for inadequate informed consent.
- Patients who received chemical abortions, their spouses, maternal grandparents (if patient was under 18 or deceased), and next of kin (if patient died from complications) — May file civil lawsuits to recover damages—including triple the cost of the abortion, medical and psychological injuries, and statutory damages—if a chemical abortion was performed or prescribed in violation of the law; however, no damages may be awarded if the pregnancy resulted from the plaintiff’s own criminal conduct.
- Abortion pill providers and health care providers who prescribe or administer abortion-inducing drugs — May be subject to civil penalties up to $10,000 per violation if courts find they failed to conduct reasonable informed consent before a chemical abortion; penalties fund pregnancy resource centers that do not perform or refer for abortions.
- Health care providers and facilities that diagnose or treat complications from chemical abortions — Must submit detailed reports on chemical abortions and complications to the Department of Health within three business days of diagnosis/treatment; failure to report incurs a $500 civil penalty per violation. Reports exclude personally identifiable patient information.
- Patients who received chemical abortions — May be required to testify or participate in legal proceedings while maintaining anonymity unless they consent to disclosure; court orders must be narrowly tailored to protect identity, and others involved in the case must use pseudonyms unless the patient consents.
Pro/Con Analysis
Stronger case for concerns
Potential Benefits (5)
Establishes strong procedural protections for patient anonymity in legal proceedings—including sealing records, use of pseudonyms, and narrow tailoring of disclosure orders—reducing stigma and privacy risks for patients involved in litigation over chemical abortion.
Rights & LibertiesPeopleRef: Sec. 1(1)-(4); Sec. 2(5), (15)Requires providers to inform patients of potential legal liability for complications, which may improve informed consent by clarifying risks and legal recourse, potentially encouraging better safety practices and transparency in prescribing.
HealthcarePeopleRef: Sec. 4(1)Mandates reporting of chemical abortions and complications to the Department of Health, which could improve public health surveillance and support research on outcomes and safety—though anonymized, aggregate data may be more useful than granular reporting.
Public SafetyPeopleRef: Sec. 5(1), (2), (6)Allows for statutory attorneys’ fees for prevailing plaintiffs, which may improve access to legal recourse for patients harmed by noncompliant care—though this also increases litigation exposure for providers.
Business & EmploymentLean peopleRef: Sec. 2(10), (11), (12)Requires written patient certification that liability information was provided, which may reduce disputes over informed consent and encourage documentation discipline—though it adds administrative burden and may not meaningfully improve patient understanding.
HealthcareLean peopleRef: Sec. 4(2), (3), (4)
Potential Concerns (5)
Mandates that providers deliver specific legal liability warnings to patients before chemical abortion, creating a burdensome administrative and documentation requirement that diverts clinical time and increases administrative overhead for providers, potentially delaying care or deterring providers from offering the service.
HealthcareIndustryRef: Sec. 4(1); Sec. 2(8), (9)Creates a broad private right of civil action allowing spouses, maternal grandparents, and next of kin to sue for damages—including triple the cost of the abortion and psychological injury—even if the patient consents to the procedure and suffers no physical harm, chilling provider willingness to offer care and exposing providers to litigation risk for subjective claims.
Rights & LibertiesIndustryRef: Sec. 2(2), (4), (13)Requires reporting of detailed patient-level data—including race, county of residence, and source of medication—to the Department of Health, which, despite anonymization claims, increases re-identification risk and may deter patients from seeking care or providers from treating complications due to privacy concerns.
HealthcareIndustryRef: Sec. 5(2)(c), (d), (f), (g), (h), (l)Imposes civil penalties up to $10,000 per violation for inadequate informed consent and $500 per unreported complication, with funds directed to pregnancy resource centers that do not provide abortion services—effectively redirecting public enforcement resources to ideological alternatives and creating financial disincentives for clinical providers to offer chemical abortion care.
Business & EmploymentLean industryRef: Sec. 2(8), (9); Sec. 5(7)While explicitly shielding patients from criminal or civil penalties, the bill’s structure—by criminalizing providers and enabling civil suits by third parties—creates a hostile legal environment that may reduce provider availability, especially in rural or underserved areas, limiting patient access to time-sensitive care.
HealthcareLean industryRef: Sec. 2(1), (5), (15); Sec. 4(1)
Who Is Most Affected
Providers face significant legal and financial exposure: civil penalties up to $10,000 per violation, mandatory documentation burdens, and liability to third parties—even if no harm occurred. This may deter providers (especially in rural or safety-net clinics) from offering chemical abortion, reducing access.
Patients gain strong privacy protections in litigation and are shielded from penalties, but may face reduced access to care due to provider flight, and may be exposed to third-party lawsuits (e.g., by grandparents or spouses) even if they consented and suffered no injury.
Pregnancy resource centers that do not perform or refer for abortions will receive penalty revenue, potentially expanding services—but this redirects public enforcement funds to ideological alternatives and may not increase overall access to comprehensive care.
Hospitals and clinics treating complications must comply with reporting requirements and may face liability if they fail to report—adding administrative burden and potentially discouraging emergency departments from documenting or treating abortion-related complications.
Patients may benefit from anonymity protections in court, but the bill’s structure may lead to delayed or denied emergency care if providers fear legal exposure for treating complications without clear documentation of prior consent.